Complete regression of choroidal metastases from breast cancer after docetaxel-based systemic chemotherapy.
Kosmas
C
C
Department of Medicine, Hematology & Medical Oncology Unit, Helena-Venizelou Hospital, Athens, Greece. ckosm@ath.forthnet.gr
Malamos
N A
NA
Antonopoulos
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D002830:Choroid Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary*; D000077143:Docetaxel; D004334:Drug Administration Schedule; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D000078224:Lenograstim; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000556:secondary; D043823:Taxoids; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000972:Antineoplastic Agents, Phytogenic; D011994:Recombinant Proteins; D043823:Taxoids; D016179:Granulocyte Colony-Stimulating Factor; D000077143:Docetaxel; D000078224:Lenograstim; D017239:Paclitaxel